¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"central gelatinous substance"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • central hearing loss
    ÁßÃßû·Â¼Ò½Ç, ÁßÃß³­Ã»
  • central hemorrhagic necrosis
    Áß½ÉÃâÇ÷±«»ç
  • central incisor
    Á߽ɾմÏ, ÁßÀýÄ¡
  • central insertion
    Á߽ɺÎÂø
  • central karyosome
    Áß½ÉÇÙ¼Òü
  • central lateral nucleus
    °¡ÂÊÁß½ÉÇÙ, Á߽ɿÜÃøÇÙ
  • central lymphoid organ
    ÁßÃ߸²ÇÁ±â°ü
  • central medial nucleus
    ¾ÈÂÊÁß½ÉÇÙ, Á߽ɳ»ÃøÇÙ
  • central necrosis
    Á߽ɱ«»ç
  • central nervous system
    ÁßÃ߽Űæ°èÅë, ÁßÃ߽Űæ°è
  • central neurogenic hyperpnea
    ÁßÃ߽Űæ°ú´ÙÈ£Èí
  • central nucleus
    Áß½ÉÇÙ
  • central pain
    ÁßÃßÅëÁõ, ÁßÃ߽ŰæÅë
  • central pain syndrome
    ÁßÃßÅëÁõÁõÈıº
  • central pulse
    Á߽ɸƹÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • acrosomal substance
    ÷´Üü¹°Áú
  • agglutinable substance
    ÀÀÁý¼º¹°Áú
  • antibacterial substance
    Ç×±Õ¹°Áú
  • antifungal substance
    Ç×Áø±Õ¹°Áú
  • antiketogenic substance
    Ç×ÄÉÅæ»ý¼º¹°Áú
  • antithyroid substance
    Ç×¹æÆÐ»ù¹°Áú, Ç×°©»ó»ù¹°Áú
  • antiyeast substance
    Ç×È¿¸ð¹°Áú
  • blood group specific substance
    Ç÷¾×ÇüƯÀ̹°Áú
  • carcinogenic substance
    ¹ß¾Ï¹°Áú
  • cement substance
    Á¢ÇÕÁú
  • chromophil substance
    (¢¡Nissl body) ´Ö½½¼Òü
  • compact substance
    Ä¡¹ÐÁú
  • conjugated estrogenic substance
    Á¢ÇÕ¹ßÁ¤¹°Áú
  • cortical substance
    °ÑÁú, ÇÇÁú
  • crystalline substance
    °áÁ¤¹°Áú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • released substance
    ¹æÃâ¹°Áú(Û¯õóÚªòõ).
  • renal pressor substance
    ½Å½Â¾Ð¹°Áú(ãìã°äâÚªòõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • lateral intermediate substance
    °¡ÂÊÁß°£È¸»öÁú
  • lens substance
    ¼öÁ¤Ã¼Áú(¡­òõ).
  • lens substance
    ¼öÁ¤Ã¼¹°Áú
  • melanophore expanding substance
    Èæ»ö¼¼Æ÷È®Àå¹°Áú(¡­á¬øàüªíåÚªòõ).
  • metachromatic substance
    ÀÌ¿°¼º ¹°Áú(ì¶æøàõÚªòõ).
  • molecular substance
    ºÐÀÚ¹°Áú(¡­Úªòõ).
  • muscular substance
    ±ÙÀ°(ÐÉë¿), ±Ù(ÐÉ).
  • muscular substance
    ±ÙÀ°Áú
  • nerve transmitter substance =neurotransmitte r
    ½Å°æÀü´Þ¹°Áú(~îîÓ¹Úªòõ).
  • nerve transmitter substance =neurotransmitter
    ½Å°æÀü´Þ¹°Áú(~îîÓ¹Úªòõ).
  • neurosecretory substance
    ½Å°æºÐºñ¹°
  • neurotransmitter =nerve transmitter substance
    ½Å°æÀü´Þ¹°Áú.
  • neurotransmitter [=nerve transmitter substance]
    ½Å°æÀü´Þ¹°Áú
  • odoriferous substance
    Çâ·á(úÅè÷).
  • osteoid substance
    Dz»À¹°Áú
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Central lobule
    Á߽ɼҿ±
    [¿¾ ¿ë¾î] ¼Ò³úÁ߽ɼҿ±
  • Ala of central lobule
    Á߽ɼҿ±³¯°³
    [¿¾ ¿ë¾î] Á߽ɼҿ±ÀÍ
  • Central thalamic radiations
    Á߽ɽûóºÎê»ì
    [¿¾ ¿ë¾î] ±Ã½É½Ã»ó¹æ»ç
  • Central thalamic radiations
    Á߽ɽûóºÎê»ì
    [¿¾ ¿ë¾î] Áß½É½Ã»ó¹æ»ç
  • Central fovea
    Á߽ɿÀ¸ñ
    [¿¾ ¿ë¾î] Á߽ɿÍ
  • Central vein
    Áß½ÉÁ¤¸Æ
    [¿¾ ¿ë¾î] Áß½ÉÁ¤¸Æ
  • Central veins
    Áß½ÉÁ¤¸Æ
    [¿¾ ¿ë¾î] Áß½ÉÁ¤¸Æ
  • Central nucleus
    Áß½ÉÇÙ
    [¿¾ ¿ë¾î] Áß½ÉÇÙ
  • CENTRAL NERVOUS SYSTEM
    ÁßÃ߽Űæ°èÅë
    [¿¾ ¿ë¾î] ÁßÃ߽Űæ°è
  • Central glial cell
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] Á߽ɽŰ汳¼¼Æ÷
  • Glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
    [¿¾ ¿ë¾î] ÁßÃß±³¼¼Æ÷
  • Short central artery
    ªÀºÁ߽ɵ¿¸Æ
    [¿¾ ¿ë¾î] ´ÜÁ߽ɵ¿¸Æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
DLTS digoxin-like immunoreactive substance
EPS ear-patella-short stature [syndrome]; elastosis perforans serpiginosa; electrophysiologic study; enz...
ESS empty sella syndrome; endostreptosin; erythrocyte-sensitizing substance; euthyroid sick syndrome; ev...
E-sub excitor substance
FMS fat-mobilizing substance; Fellow of the Medical Society; fibromyalgia syndrome; full mouth series
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
SP-IR Substance P immunoreactive
SP-IR Substance P immunoreactivity
SPLI Substance P like immunoreactivity
SPR Substance P receptor
SP-LI Substance P-like immunoreactive
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • central giant cell tumor
    Á߽ɼº °Å´ë ¼¼Æ÷ ¾ÏÁ¾
  • central groove
    Á᫐ ±¸
    ±¸Ä¡¿¡ À־ ¼³Ãø ±³µÎ¿Í ÇùÃø ±³µÎ »çÀÌ¿¡ Çü¼ºµÈ ±¸·Î½á ±Ù½É ¼Ò¿Í¿¡¼­ Á᫐ ¼Ò¿Í, ¿ø½É ¼Ò¿Í¸¦ ¿¬°áÇÏ°Ô µÇ¸ç ±³ÇÕ¸éÀ» ÇùÃø ¹ÝºÎ¿Í ¼³Ãø ¹ÝºÎ·Î ³ª´«´Ù.
  • central heating
    Áß¾Ó ³­¹æ
  • central hemorrhagic necrosis
    ÃâÇ÷¼º Á᫐ Á¤¾× ±«»ç
  • central incisor
    ÁßÀýÄ¡
    À½½ÄÀ» Àý´ÜÇϴµ¥ ¾²ÀÌ´Â ÀýÄ¡ Áß Á¤Áß¼±¿¡¼­ ù ¹øÂ°¿¡ À§Ä¡Çϰí Á¿ì·Î 1°³¾¿ ÀÖÀ¸¸ç ÀýÄ¡ Áß °¡Àå Å©°í ±Ù¿ø½É°æÀÌ ¼ø¼³°æº¸´Ù Å« Ä¡¾ÆÀÌ´Ù. ¼ø¸é¿¡¼­ º¸¾ÒÀ» ¶§ ±Ù½É¿¬Àº Á÷¼±ÀûÀÌ°í ±æ¸ç ¿ø½É¿¬Àº °î¼±ÀûÀ̰í ª´Ù. ±×¸®°í Áß¾Ó¼ø¿¬ À¶¼±À» Áß½ÉÀ¸·Î ±Ù½É ¹ÝºÎ´Â ¿ø½É ¹ÝºÎº¸´Ù Å©´Ù. Àý´Ü¿¬Àº ±Ù½É¿¡¼­ ¿ø½ÉÀ¸·Î Ä¡°æÃøÀ» ÇâÇØ °æ»çÁ® ÀÖ°í ¼³¸é °áÀýÀÇ Á¤Á¡ÀÌ ¾à°£ ¿ø½ÉÃø¿¡ À§Ä¡ÇÑ´Ù. ±Ù½É¿¬Àº ¿ø½É¿¬º¸´Ù ³Ð°í ÆòźÇϸç Ä¡°æ¼±ÀÇ ¸¸°îµµµµ ´õ Å©´Ù. Ä¡¾ÆÀÇ 3»ó¡ÀÎ ¿ì°¢ »ó¡, ¸¸°î »ó¡, Ä¡±Ù »ó¡ÀÌ Àß ³ªÅ¸³ª¸ç ´Ü±ÙÄ¡À̰í ÀüüÀûÀ¸·Î ±½Àº ¿øÃßÇüÀ» Çϰí ÀÖ´Ù.
  • central inhibitory connection
    ÁßÃß ¾ïÁ¦ ¿¬°á
  • central insertion
    Á᫐ ºÎÂø
  • central lateral
    Áß½É Ãø¹æ
  • central light
    Á᫐ ±¤
  • central lobule of cerebellum
    ¼Ò³ú Áß½É
  • central lymphatic organ
    ÁßÃß ÀÓÆÄ°è ±â°ü, ÁßÃß ¸²ÇÁ Á¶Á÷ Àå±â
    Ç×ü »ý»ê ¹× ¼¼Æ÷ ¸é¿ª¿¡ °ü¿©ÇÏ´Â ¸é¿ª Á¶Á÷ Áß¿¡¼­ °£ ¼¼Æ÷·ÎºÎÅÍ ¸é¿ª Ȱ¼º ¼¼Æ÷·ÎÀÇ ºÐÈ­ÀÇ Àå¼Ò°¡ µÇ´Â ¸²ÇÁ Á¶Á÷À» ÁßÃß ¸²ÇÁ Á¶Á÷À̶ó°í ºÎ¸¥´Ù. À̰Ϳ¡´Â Èä¼±, Á¶·ù¿¡¼­´Â Fabricius³¶, Æ÷À¯·ù¿¡¼­´Â À̰Ͱú À¯»çÇÑ Á¶Á÷ÀÌ Æ÷ÇԵȴÙ.
  • central mucoepidermoid carcinoma
    °ñ³» Á¡¾× Ç¥ÇǾÏ
    »ó, ÇϾǿ¡ Áß½ÉÀûÀ¸·Î ¹ß»ýÇϸç, ¹è¹ß»ý±â¿¡ Ÿ¾×¼± ¼¼Æ÷°¡ À¯ÀԵǾú°Å³ª Ä¡¼º ³¶ÀÇ Á¡¾× ¼¼Æ÷°¡ Á¾¾çÀ¸·Î ÀüȯµÇ¾î »ý±æ ¼ö ÀÖ´Ù.
  • central necrosis
    Á᫐ ±«»ç
  • central nerve system mechanism
    ÁßÃß ½Å°æ°è ±âÀü
  • central nervous system mechanism
    ÁßÃß ½Å°æ°è ±âÀü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
substance-induced organic mental disorders Mental disorders caused by use of drugs, e.g., cocaine.
(05 Mar 2000)
substance of lens of eye That which constitutes the lens of the eye, composed of a nucleus and a cortex and covered by an epithelium.
Synonym: substantia lentis.
(05 Mar 2000)
substance P A vasoactive intestinal peptide (1348 D) found in the brain, spinal ganglia and intestine of vertebrates. Induces vasodilatation, salivation and increases capillary permeability. Sequence: RPKPQFFGLM.
(18 Nov 1997)
substance-related disorders These non-psychotic disorders include those related to the taking of a drug of abuse (including alcohol), to the side effects of a medication, and to toxin exposure.
(12 Dec 1998)
substance withdrawal syndrome <syndrome> Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
(12 Dec 1998)
innominate substance The region of the forebrain that lies ventral to the anterior half or so of the lentiform nucleus, extending in the frontal plane from the lateral preopticohypothalamic zone laterally over the optic tract to the amygdala (amygdaloid body); rostrally it tapers off over the dorsal border of the olfactory tubercle, caudally it ends where the internal capsule reaches the surface to form the cerebral peduncle or pes pedunculi. Notable among its polymorphic cell population is the large-celled basal nucleus of Meynert. These magnocellular elements within the substantia i. Are present in the medial septum and the diagonal band of Broca, but occur in largest numbers ventral to the globus pallidus. Histochemical evidence indicates that magnocellular elements distribute cholinergic fibres widely in the cerebral cortex and that these cells undergo selective degeneration in Alzheimer's disease.
Synonym: substantia innominata.
(05 Mar 2000)
interspongioplastic substance An obsolete term for cytochylema.
(05 Mar 2000)
threshold substance Any material (e.g., glucose) that is excreted in the urine only when its plasma concentration exceeds a certain value, termed its threshold.
Synonym: threshold body.
(05 Mar 2000)
tigroid substance The material consisting of granular endoplasmic reticulum and ribosomes that occurs in nerve cell bodies and dendrites.
Synonym: basophil substance, basophilic substance, chromophil substance, Nissl bodies, Nissl granules, substantia basophilia, tigroid bodies, tigroid substance.
(05 Mar 2000)
ergastic substance Metabolically inert products of photosynthesis, such as starch grains and fat globules.
(18 Nov 1997)
exophthalmos-producing substance A factor found in crude extract of pituitary tissue that produced exophthalmos in laboratory animals (especially fish). Its existence and role in producing exophthalmopathy in Graves' disease is questioned.
(05 Mar 2000)
Kendall's substance A group of corticosteroids. Kendall's compound A (11-dehydrocorticosterone); Kendall's compound B (corticosterone); Kendall's compound E (cortisone); Kendall's compound F (cortisol).
Synonym: Kendall's substance.
(05 Mar 2000)
united states substance abuse and mental health services administration An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to substance abuse and mental health. It is commonly referred to by the acronym samhsa. On 1 october 1992, the united states alcohol, drug abuse, and mental health administration (adamha) became samhsa. (telephone communication with samhsa 7 april 1992)
(12 Dec 1998)
zymoplastic substance <haematology> Traditional name for substance in plasma that converts prothrombin to thrombin. Now known not to be a single substance. (See thrombin).
(18 Nov 1997)
filar substance A filamentous plasmatic material, beaded with granules, demonstrable by means of vital staining in the immature red blood cells.
Synonym: alpha substance, filar mass, filar substance, substantia reticularis, substantia reticulofilamentosa.
Synonym: reticular formation.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á